Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (439)	10/29/2002 12:53:42 PM
From: Icebrg	Read Replies (1) \| Respond to of 1022

Harold No, they plan to finish the plant expansion and use the manufacturing capacity as an argument to lure potential partners into the Abgenix net. Makes sense. Their strategy should be contrasted with Medarex, who recently decided not to go forward with their plant expansion quoting the available "excess" capacity as the reason. Makes less sense. I suppose both of them cannot be right. What is clear though is that both (having cash nets of abt 200 mUSD each after deducting long-term debts) start to feel a squeeze on the cash position. Amazing! Erik